Global Circulating Tumor Cells Market Growth (Status and Outlook) 2019-2024

Publisher Name :
Date: 21-Feb-2019
No. of pages: 137

Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of these markers in monitoring disease progression and potentially guiding personalized cancer therapy.

USA is the largest supplier of CTCs Products, with a revenue market share nearly 47.41% in 2017. Europe is the second largest supplier of CTCs products, enjoying revenue market share nearly 26.24% in 2017. Asia has the highest growth rate. Vendors recognize the importance of this region, particularly in China, India and are working towards penetrating this market by strengthening their sales and distribution networks.

According to this study, over the next five years the Circulating Tumor Cells market will register a 20.1% CAGR in terms of revenue, the global market size will reach US$ 2200 million by 2024, from US$ 730 million in 2019. In particular, this report presents the global revenue market share of key companies in Circulating Tumor Cells business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of Circulating Tumor Cells market by product type, application, key companies and key regions.

This study considers the Circulating Tumor Cells value generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.

- CTC Enrichment

- CTC Detection

Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.

- Breast Cancer

- Prostate Cancer

- Colorectal Cancer

- Lung Cancer

- Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

- Americas

- - United States

- - Canada

- - Mexico

- - Brazil

- APAC

- - China

- - Japan

- - Korea

- - Southeast Asia

- - India

- - Australia

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Spain

- Middle East & Africa

- - Egypt

- - South Africa

- - Israel

- - Turkey

- - GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

- Menarini-Silicon Biosystems

- Qiagen (Adnagen)

- Advanced Cell Diagnostics

- ApoCell

- Epic Sciences

- Greiner Bio-one GmbH

- Cynvenio

- SurExamBio-Tech

- Fluxion Biosciences

- Ikonisys

- Hangzhou Watson Biotech

- Biocept

- CytoTrack

- Guangzhou Wondfo Biotech

- Celsee

- Clearbridge Biomedics

- ANGLE plc

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

- To study and analyze the global Circulating Tumor Cells market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.

- To understand the structure of Circulating Tumor Cells market by identifying its various subsegments.

- Focuses on the key global Circulating Tumor Cells players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the Circulating Tumor Cells with respect to individual growth trends, future prospects, and their contribution to the total market.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- To project the size of Circulating Tumor Cells submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

Global Circulating Tumor Cells Market Growth (Status and Outlook) 2019-2024

Table of Contents

2019-2024 Global Circulating Tumor Cells Market Report (Status and Outlook)

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Circulating Tumor Cells Market Size 2014-2024
2.1.2 Circulating Tumor Cells Market Size CAGR by Region
2.2 Circulating Tumor Cells Segment by Type
2.2.1 CTC Enrichment
2.2.2 CTC Detection
2.2.3 CTC Analysis
2.3 Circulating Tumor Cells Market Size by Type
2.3.1 Global Circulating Tumor Cells Market Size Market Share by Type (2014-2019)
2.3.2 Global Circulating Tumor Cells Market Size Growth Rate by Type (2014-2019)
2.4 Circulating Tumor Cells Segment by Application
2.4.1 Breast Cancer
2.4.2 Prostate Cancer
2.4.3 Colorectal Cancer
2.4.4 Lung Cancer
2.4.5 Other
2.5 Circulating Tumor Cells Market Size by Application
2.5.1 Global Circulating Tumor Cells Market Size Market Share by Application (2014-2019)
2.5.2 Global Circulating Tumor Cells Market Size Growth Rate by Application (2014-2019)

3 Global Circulating Tumor Cells by Players
3.1 Global Circulating Tumor Cells Market Size Market Share by Players
3.1.1 Global Circulating Tumor Cells Market Size by Players (2017-2019)
3.1.2 Global Circulating Tumor Cells Market Size Market Share by Players (2017-2019)
3.2 Global Circulating Tumor Cells Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Circulating Tumor Cells by Regions
4.1 Circulating Tumor Cells Market Size by Regions
4.2 Americas Circulating Tumor Cells Market Size Growth
4.3 APAC Circulating Tumor Cells Market Size Growth
4.4 Europe Circulating Tumor Cells Market Size Growth
4.5 Middle East & Africa Circulating Tumor Cells Market Size Growth

5 Americas
5.1 Americas Circulating Tumor Cells Market Size by Countries
5.2 Americas Circulating Tumor Cells Market Size by Type
5.3 Americas Circulating Tumor Cells Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Circulating Tumor Cells Market Size by Countries
6.2 APAC Circulating Tumor Cells Market Size by Type
6.3 APAC Circulating Tumor Cells Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Circulating Tumor Cells by Countries
7.2 Europe Circulating Tumor Cells Market Size by Type
7.3 Europe Circulating Tumor Cells Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Circulating Tumor Cells by Countries
8.2 Middle East & Africa Circulating Tumor Cells Market Size by Type
8.3 Middle East & Africa Circulating Tumor Cells Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Circulating Tumor Cells Market Forecast
10.1 Global Circulating Tumor Cells Market Size Forecast (2019-2024)
10.2 Global Circulating Tumor Cells Forecast by Regions
10.2.1 Global Circulating Tumor Cells Forecast by Regions (2019-2024)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Circulating Tumor Cells Forecast by Type
10.8 Global Circulating Tumor Cells Forecast by Application

11 Key Players Analysis
11.1 Menarini-Silicon Biosystems
11.1.1 Company Details
11.1.2 Circulating Tumor Cells Product Offered
11.1.3 Menarini-Silicon Biosystems Circulating Tumor Cells Revenue, Gross Margin and Market Share (2017-2019)
11.1.4 Main Business Overview
11.1.5 Menarini-Silicon Biosystems News
11.2 Qiagen (Adnagen)
11.2.1 Company Details
11.2.2 Circulating Tumor Cells Product Offered
11.2.3 Qiagen (Adnagen) Circulating Tumor Cells Revenue, Gross Margin and Market Share (2017-2019)
11.2.4 Main Business Overview
11.2.5 Qiagen (Adnagen) News
11.3 Advanced Cell Diagnostics
11.3.1 Company Details
11.3.2 Circulating Tumor Cells Product Offered
11.3.3 Advanced Cell Diagnostics Circulating Tumor Cells Revenue, Gross Margin and Market Share (2017-2019)
11.3.4 Main Business Overview
11.3.5 Advanced Cell Diagnostics News
11.4 ApoCell
11.4.1 Company Details
11.4.2 Circulating Tumor Cells Product Offered
11.4.3 ApoCell Circulating Tumor Cells Revenue, Gross Margin and Market Share (2017-2019)
11.4.4 Main Business Overview
11.4.5 ApoCell News
11.5 Epic Sciences
11.5.1 Company Details
11.5.2 Circulating Tumor Cells Product Offered
11.5.3 Epic Sciences Circulating Tumor Cells Revenue, Gross Margin and Market Share (2017-2019)
11.5.4 Main Business Overview
11.5.5 Epic Sciences News
11.6 Greiner Bio-one GmbH
11.6.1 Company Details
11.6.2 Circulating Tumor Cells Product Offered
11.6.3 Greiner Bio-one GmbH Circulating Tumor Cells Revenue, Gross Margin and Market Share (2017-2019)
11.6.4 Main Business Overview
11.6.5 Greiner Bio-one GmbH News
11.7 Cynvenio
11.7.1 Company Details
11.7.2 Circulating Tumor Cells Product Offered
11.7.3 Cynvenio Circulating Tumor Cells Revenue, Gross Margin and Market Share (2017-2019)
11.7.4 Main Business Overview
11.7.5 Cynvenio News
11.8 SurExamBio-Tech
11.8.1 Company Details
11.8.2 Circulating Tumor Cells Product Offered
11.8.3 SurExamBio-Tech Circulating Tumor Cells Revenue, Gross Margin and Market Share (2017-2019)
11.8.4 Main Business Overview
11.8.5 SurExamBio-Tech News
11.9 Fluxion Biosciences
11.9.1 Company Details
11.9.2 Circulating Tumor Cells Product Offered
11.9.3 Fluxion Biosciences Circulating Tumor Cells Revenue, Gross Margin and Market Share (2017-2019)
11.9.4 Main Business Overview
11.9.5 Fluxion Biosciences News
11.10 Ikonisys
11.10.1 Company Details
11.10.2 Circulating Tumor Cells Product Offered
11.10.3 Ikonisys Circulating Tumor Cells Revenue, Gross Margin and Market Share (2017-2019)
11.10.4 Main Business Overview
11.10.5 Ikonisys News
11.11 Hangzhou Watson Biotech
11.12 Biocept
11.13 CytoTrack
11.14 Guangzhou Wondfo Biotech
11.15 Celsee
11.16 Clearbridge Biomedics
11.17 ANGLE plc

12 Research Findings and Conclusion

List of Tables and Figures

Table Product Specifications of Circulating Tumor Cells
Figure Circulating Tumor Cells Report Years Considered
Figure Market Research Methodology
Figure Global Circulating Tumor Cells Market Size Growth Rate 2014-2024 ($ Millions)
Table Circulating Tumor Cells Market Size CAGR by Region 2014-2024 ($ Millions)
Table Major Players of CTC Enrichment
Table Major Players of CTC Detection
Table Major Players of CTC Analysis
Table Market Size by Type (2014-2019) ($ Millions)
Table Global Circulating Tumor Cells Market Size Market Share by Type (2014-2019)
Figure Global Circulating Tumor Cells Market Size Market Share by Type (2014-2019)
Figure Global CTC Enrichment Market Size Growth Rate
Figure Global CTC Detection Market Size Growth Rate
Figure Global CTC Analysis Market Size Growth Rate
Figure Circulating Tumor Cells Consumed in Breast Cancer
Figure Global Circulating Tumor Cells Market: Breast Cancer (2014-2019) ($ Millions)
Figure Global Breast Cancer YoY Growth ($ Millions)
Figure Circulating Tumor Cells Consumed in Prostate Cancer
Figure Global Circulating Tumor Cells Market: Prostate Cancer (2014-2019) ($ Millions)
Figure Global Prostate Cancer YoY Growth ($ Millions)
Figure Circulating Tumor Cells Consumed in Colorectal Cancer
Figure Global Circulating Tumor Cells Market: Colorectal Cancer (2014-2019) ($ Millions)
Figure Global Colorectal Cancer YoY Growth ($ Millions)
Figure Circulating Tumor Cells Consumed in Lung Cancer
Figure Global Circulating Tumor Cells Market: Lung Cancer (2014-2019) ($ Millions)
Figure Global Lung Cancer YoY Growth ($ Millions)
Figure Circulating Tumor Cells Consumed in Other
Figure Global Circulating Tumor Cells Market: Other (2014-2019) ($ Millions)
Figure Global Other YoY Growth ($ Millions)
Table Global Circulating Tumor Cells Market Size by Application (2014-2019) ($ Millions)
Table Global Circulating Tumor Cells Market Size Market Share by Application (2014-2019)
Figure Global Circulating Tumor Cells Market Size Market Share by Application (2014-2019)
Figure Global Circulating Tumor Cells Market Size in Breast Cancer Growth Rate
Figure Global Circulating Tumor Cells Market Size in Prostate Cancer Growth Rate
Figure Global Circulating Tumor Cells Market Size in Colorectal Cancer Growth Rate
Figure Global Circulating Tumor Cells Market Size in Lung Cancer Growth Rate
Figure Global Circulating Tumor Cells Market Size in Other Growth Rate
Table Global Circulating Tumor Cells Revenue by Players (2017-2019) ($ Millions)
Table Global Circulating Tumor Cells Revenue Market Share by Players (2017-2019)
Figure Global Circulating Tumor Cells Revenue Market Share by Players in 2018
Table Global Circulating Tumor Cells Key Players Head office and Products Offered
Table Circulating Tumor Cells Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table Global Circulating Tumor Cells Market Size by Regions 2014-2019 ($ Millions)
Table Global Circulating Tumor Cells Market Size Market Share by Regions 2014-2019
Figure Global Circulating Tumor Cells Market Size Market Share by Regions 2014-2019
Figure Americas Circulating Tumor Cells Market Size 2014-2019 ($ Millions)
Figure APAC Circulating Tumor Cells Market Size 2014-2019 ($ Millions)
Figure Europe Circulating Tumor Cells Market Size 2014-2019 ($ Millions)
Figure Middle East & Africa Circulating Tumor Cells Market Size 2014-2019 ($ Millions)
Table Americas Circulating Tumor Cells Market Size by Countries (2014-2019) ($ Millions)
Table Americas Circulating Tumor Cells Market Size Market Share by Countries (2014-2019)
Figure Americas Circulating Tumor Cells Market Size Market Share by Countries in 2018
Table Americas Circulating Tumor Cells Market Size by Type (2014-2019) ($ Millions)
Table Americas Circulating Tumor Cells Market Size Market Share by Type (2014-2019)
Figure Americas Circulating Tumor Cells Market Size Market Share by Type in 2018
Table Americas Circulating Tumor Cells Market Size by Application (2014-2019) ($ Millions)
Table Americas Circulating Tumor Cells Market Size Market Share by Application (2014-2019)
Figure Americas Circulating Tumor Cells Market Size Market Share by Application in 2018
Figure United States Circulating Tumor Cells Market Size Growth 2014-2019 ($ Millions)
Figure Canada Circulating Tumor Cells Market Size Growth 2014-2019 ($ Millions)
Figure Mexico Circulating Tumor Cells Market Size Growth 2014-2019 ($ Millions)
Table APAC Circulating Tumor Cells Market Size by Countries (2014-2019) ($ Millions)
Table APAC Circulating Tumor Cells Market Size Market Share by Countries (2014-2019)
Figure APAC Circulating Tumor Cells Market Size Market Share by Countries in 2018
Table APAC Circulating Tumor Cells Market Size by Type (2014-2019) ($ Millions)
Table APAC Circulating Tumor Cells Market Size Market Share by Type (2014-2019)
Figure APAC Circulating Tumor Cells Market Size Market Share by Type in 2018
Table APAC Circulating Tumor Cells Market Size by Application (2014-2019) ($ Millions)
Table APAC Circulating Tumor Cells Market Size Market Share by Application (2014-2019)
Figure APAC Circulating Tumor Cells Market Size Market Share by Application in 2018
Figure China Circulating Tumor Cells Market Size Growth 2014-2019 ($ Millions)
Figure Japan Circulating Tumor Cells Market Size Growth 2014-2019 ($ Millions)
Figure Korea Circulating Tumor Cells Market Size Growth 2014-2019 ($ Millions)
Figure Southeast Asia Circulating Tumor Cells Market Size Growth 2014-2019 ($ Millions)
Figure India Circulating Tumor Cells Market Size Growth 2014-2019 ($ Millions)
Figure Australia Circulating Tumor Cells Market Size Growth 2014-2019 ($ Millions)
Table Europe Circulating Tumor Cells Market Size by Countries (2014-2019) ($ Millions)
Table Europe Circulating Tumor Cells Market Size Market Share by Countries (2014-2019)
Figure Europe Circulating Tumor Cells Market Size Market Share by Countries in 2018
Table Europe Circulating Tumor Cells Market Size by Type (2014-2019) ($ Millions)
Table Europe Circulating Tumor Cells Market Size Market Share by Type (2014-2019)
Figure Europe Circulating Tumor Cells Market Size Market Share by Type in 2018
Table Europe Circulating Tumor Cells Market Size by Application (2014-2019) ($ Millions)
Table Europe Circulating Tumor Cells Market Size Market Share by Application (2014-2019)
Figure Europe Circulating Tumor Cells Market Size Market Share by Application in 2018
Figure Germany Circulating Tumor Cells Market Size Growth 2014-2019 ($ Millions)
Figure France Circulating Tumor Cells Market Size Growth 2014-2019 ($ Millions)
Figure UK Circulating Tumor Cells Market Size Growth 2014-2019 ($ Millions)
Figure Italy Circulating Tumor Cells Market Size Growth 2014-2019 ($ Millions)
Figure Russia Circulating Tumor Cells Market Size Growth 2014-2019 ($ Millions)
Figure Spain Circulating Tumor Cells Market Size Growth 2014-2019 ($ Millions)
Table Middle East & Africa Circulating Tumor Cells Market Size by Countries (2014-2019) ($ Millions)
Table Middle East & Africa Circulating Tumor Cells Market Size Market Share by Countries (2014-2019)
Figure Middle East & Africa Circulating Tumor Cells Market Size Market Share by Countries in 2018
Table Middle East & Africa Circulating Tumor Cells Market Size by Type (2014-2019) ($ Millions)
Table Middle East & Africa Circulating Tumor Cells Market Size Market Share by Type (2014-2019)
Figure Middle East & Africa Circulating Tumor Cells Market Size Market Share by Type in 2018
Table Middle East & Africa Circulating Tumor Cells Market Size by Application (2014-2019) ($ Millions)
Table Middle East & Africa Circulating Tumor Cells Market Size Market Share by Application (2014-2019)
Figure Middle East & Africa Circulating Tumor Cells Market Size Market Share by Application in 2018
Figure Egypt Circulating Tumor Cells Market Size Growth 2014-2019 ($ Millions)
Figure South Africa Circulating Tumor Cells Market Size Growth 2014-2019 ($ Millions)
Figure Israel Circulating Tumor Cells Market Size Growth 2014-2019 ($ Millions)
Figure Turkey Circulating Tumor Cells Market Size Growth 2014-2019 ($ Millions)
Figure GCC Countries Circulating Tumor Cells Market Size Growth 2014-2019 ($ Millions)
Figure Global Circulating Tumor Cells arket Size Forecast (2019-2024) ($ Millions)
Table Global Circulating Tumor Cells Market Size Forecast by Regions (2019-2024) ($ Millions)
Table Global Circulating Tumor Cells Market Size Market Share Forecast by Regions
Figure Americas Circulating Tumor Cells Market Size 2019-2024 ($ Millions)
Figure APAC Circulating Tumor Cells Market Size 2019-2024 ($ Millions)
Figure Europe Circulating Tumor Cells Market Size 2019-2024 ($ Millions)
Figure Middle East & Africa Circulating Tumor Cells Market Size 2019-2024 ($ Millions)
Figure United States Circulating Tumor Cells Market Size 2019-2024 ($ Millions)
Figure Canada Circulating Tumor Cells Market Size 2019-2024 ($ Millions)
Figure Mexico Circulating Tumor Cells Market Size 2019-2024 ($ Millions)
Figure Brazil Circulating Tumor Cells Market Size 2019-2024 ($ Millions)
Figure China Circulating Tumor Cells Market Size 2019-2024 ($ Millions)
Figure Japan Circulating Tumor Cells Market Size 2019-2024 ($ Millions)
Figure Korea Circulating Tumor Cells Market Size 2019-2024 ($ Millions)
Figure Southeast Asia Circulating Tumor Cells Market Size 2019-2024 ($ Millions)
Figure India Circulating Tumor Cells Market Size 2019-2024 ($ Millions)
Figure Australia Circulating Tumor Cells Market Size 2019-2024 ($ Millions)
Figure Germany Circulating Tumor Cells Market Size 2019-2024 ($ Millions)
Figure France Circulating Tumor Cells Market Size 2019-2024 ($ Millions)
Figure UK Circulating Tumor Cells Market Size 2019-2024 ($ Millions)
Figure Italy Circulating Tumor Cells Market Size 2019-2024 ($ Millions)
Figure Russia Circulating Tumor Cells Market Size 2019-2024 ($ Millions)
Figure Spain Circulating Tumor Cells Market Size 2019-2024 ($ Millions)
Figure Egypt Circulating Tumor Cells Market Size 2019-2024 ($ Millions)
Figure South Africa Circulating Tumor Cells Market Size 2019-2024 ($ Millions)
Figure Israel Circulating Tumor Cells Market Size 2019-2024 ($ Millions)
Figure Turkey Circulating Tumor Cells Market Size 2019-2024 ($ Millions)
Figure GCC Countries Circulating Tumor Cells Market Size 2019-2024 ($ Millions)
Table Global Circulating Tumor Cells Market Size Forecast by Type (2019-2024) ($ Millions)
Table Global Circulating Tumor Cells Market Size Market Share Forecast by Type (2019-2024)
Table Global Circulating Tumor Cells Market Size Forecast by Application (2019-2024) ($ Millions)
Table Global Circulating Tumor Cells Market Size Market Share Forecast by Application (2019-2024)
Table Menarini-Silicon Biosystems Basic Information, Head Office, Major Market Areas and Its Competitors
Table Menarini-Silicon Biosystems Circulating Tumor Cells Revenue and Gross Margin (2017-2019)
Figure Menarini-Silicon Biosystems Circulating Tumor Cells Market Share (2017-2019)
Table Qiagen (Adnagen) Basic Information, Head Office, Major Market Areas and Its Competitors
Table Qiagen (Adnagen) Circulating Tumor Cells Revenue and Gross Margin (2017-2019)
Figure Qiagen (Adnagen) Circulating Tumor Cells Market Share (2017-2019)
Table Advanced Cell Diagnostics Basic Information, Head Office, Major Market Areas and Its Competitors
Table Advanced Cell Diagnostics Circulating Tumor Cells Revenue and Gross Margin (2017-2019)
Figure Advanced Cell Diagnostics Circulating Tumor Cells Market Share (2017-2019)
Table ApoCell Basic Information, Head Office, Major Market Areas and Its Competitors
Table ApoCell Circulating Tumor Cells Revenue and Gross Margin (2017-2019)
Figure ApoCell Circulating Tumor Cells Market Share (2017-2019)
Table Epic Sciences Basic Information, Head Office, Major Market Areas and Its Competitors
Table Epic Sciences Circulating Tumor Cells Revenue and Gross Margin (2017-2019)
Figure Epic Sciences Circulating Tumor Cells Market Share (2017-2019)
Table Greiner Bio-one GmbH Basic Information, Head Office, Major Market Areas and Its Competitors
Table Greiner Bio-one GmbH Circulating Tumor Cells Revenue and Gross Margin (2017-2019)
Figure Greiner Bio-one GmbH Circulating Tumor Cells Market Share (2017-2019)
Table Cynvenio Basic Information, Head Office, Major Market Areas and Its Competitors
Table Cynvenio Circulating Tumor Cells Revenue and Gross Margin (2017-2019)
Figure Cynvenio Circulating Tumor Cells Market Share (2017-2019)
Table SurExamBio-Tech Basic Information, Head Office, Major Market Areas and Its Competitors
Table SurExamBio-Tech Circulating Tumor Cells Revenue and Gross Margin (2017-2019)
Figure SurExamBio-Tech Circulating Tumor Cells Market Share (2017-2019)
Table Fluxion Biosciences Basic Information, Head Office, Major Market Areas and Its Competitors
Table Fluxion Biosciences Circulating Tumor Cells Revenue and Gross Margin (2017-2019)
Figure Fluxion Biosciences Circulating Tumor Cells Market Share (2017-2019)
Table Ikonisys Basic Information, Head Office, Major Market Areas and Its Competitors
Table Ikonisys Circulating Tumor Cells Revenue and Gross Margin (2017-2019)
Figure Ikonisys Circulating Tumor Cells Market Share (2017-2019)
Table Hangzhou Watson Biotech Basic Information, Head Office, Major Market Areas and Its Competitors
Table Biocept Basic Information, Head Office, Major Market Areas and Its Competitors
Table CytoTrack Basic Information, Head Office, Major Market Areas and Its Competitors
Table Guangzhou Wondfo Biotech Basic Information, Head Office, Major Market Areas and Its Competitors
Table Celsee Basic Information, Head Office, Major Market Areas and Its Competitors
Table Clearbridge Biomedics Basic Information, Head Office, Major Market Areas and Its Competitors
Table ANGLE plc Basic Information, Head Office, Major Market Areas and Its Competitors
  • Global Circulating Tumor Cells Market Size, Status and Forecast 2019-2025
    Published: 15-Mar-2019        Price: US 3900 Onwards        Pages: 106
    Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of these markers in monitoring disease progression and potentially guiding personalized cancer therapy. USA is the largest supplier of CTCs Products, with a revenue market share nearly 47.41% in 2017. Europe is the second largest supplier of CTCs products......
  • Global Cancer Pain Therapeutics Market Research Report 2019
    Published: 13-Mar-2019        Price: US 2900 Onwards        Pages: 101
    Pain in cancer may come from compressing or infiltrating nearby body parts, from treatments and diagnostic procedures or from skin, nerve, and the other changes caused by a hormone imbalance or immune response. Factors such as the unmet medical needs of patients drive the market growth during the forecast period. Currently, the drugs that are available for reducing pains associated with cancer have a prolonged duration of action and are characterized by undesirable effects like sedation a......
  • Global Cancer Supportive Care Market Research Report 2019
    Published: 13-Mar-2019        Price: US 2900 Onwards        Pages: 90
    The cancer supportive care product market consists of drugs intended to prevent or treat the symptoms of cancer, and reduce the side effects of cancer treatments. Instead of extending a patient's life expectancy, the emphasis is on improving overall quality of life. With growing prevalence of cancer, the demand for cancer treatments, such as chemotherapy has also been consistently on the rise since the past decade. However, radiation therapy brings with it a host of side effects that are ......
  • Global Actinic Keratosis Treatment Market Size, Status and Forecast 2019-2025
    Published: 11-Mar-2019        Price: US 3900 Onwards        Pages: 94
    Actinic keratosis (AKs or solar keratoses) are keratotic macules, papules, or plaques resulting from the intraepidermal proliferation of atypical keratinocytes in response to prolonged exposure to ultraviolet radiation. It's most commonly found on the face, lips, ears, back of your hands, forearms, scalp or neck. The classification of Actinic Keratosis Treatment includes Destructive Treatment, Photodynamic Therapy, Topical Medications and Other, and the Most of Actinic Keratosis Treatment......
  • Cancer Gene Therapy Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 08-Mar-2019        Price: US 3000 Onwards        Pages: 136
    Cancer Gene Therapy Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Cancer Gene Therapy industry with a focus on the Chinese market. The report provides key statistics on the market status of the Cancer Gene Therapy manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-depth insight of 2014-2024 global and Chinese Cancer......
  • Cancer Therapeutics and Biotherapeutic Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 08-Mar-2019        Price: US 3000 Onwards        Pages: 147
    Cancer Therapeutics and Biotherapeutic Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Cancer Therapeutics and Biotherapeutic industry with a focus on the Chinese market. The report provides key statistics on the market status of the Cancer Therapeutics and Biotherapeutic manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides a......
  • Circulating Tumor Cells Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 07-Mar-2019        Price: US 3000 Onwards        Pages: 150
    Circulating Tumor Cells Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Circulating Tumor Cells industry with a focus on the Chinese market. The report provides key statistics on the market status of the Circulating Tumor Cells manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-depth insight of 2014-2024 global and Ch......
  • Global Circulating Tumor Cells Market 2019 by Company, Regions, Type and Application, Forecast to 2024
    Published: 05-Mar-2019        Price: US 3480 Onwards        Pages: 138
    Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of these markers in monitoring disease progression and potentially guiding personalized cancer therapy. Scope of the Report: USA is the largest supplier of CTCs Products, with a revenue market share nearly 47.41% in 2017. Europe is the seco......
  • Endometrial Cancer Treatments Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 02-Mar-2019        Price: US 3000 Onwards        Pages: 135
    Endometrial Cancer Treatments Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Endometrial Cancer Treatments industry with a focus on the Chinese market. The report provides key statistics on the market status of the Endometrial Cancer Treatments manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-depth insight of 2014-......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs